Correlation between Serum Lipid Profile with Anthropometric and Clinical Variables in Patients with Type 2 Diabetes Mellitus by Belete Biadgo, Solomon Mekonnen Abebe, Habtamu Wondifraw Baynes, Mohammed Yesuf, Aynadis Alemu, Molla Abebe
    Correlation between Lipid Profile with Anthropometric and …             Belete B. et al                                    
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v27i3.3 
 
215 
ORIGINAL ARTICLE 
 
Correlation between Serum Lipid Profile with Anthropometric and 
Clinical Variables in Patients with Type 2 Diabetes Mellitus  
 
Belete Biadgo
1*
, Solomon Mekonnen Abebe
2
, Habtamu Wondifraw Baynes
1
, 
Mohammed Yesuf
3
, Aynadis Alemu
1
, Molla Abebe
1
 
 
 
 
 
 
OPEN ACCESS 
 
 
Citation: Belete Biadgo,  Solomon 
Mekonnen Abebe,Habtamu Wondufraw 
Baynes, Mohammed Yesuf,Aynadis 
Alemu.Correlation between Serum Lipid 
Profile with Anthropometric and Clinical 
Variables in Patients with Type 2 
Diabetes Mellitus at University of 
Gondar Hospital, Northwest Ethiopia. 
Ethiop J Health Sci 2017;27(3):215. doi: 
http://dx.doi.org/10.4314/ejhs.v27i3.3 
Received: August 9, 2016 
Accepted December 10 , 2016 
Published: May 1, 2017 
Copyright: © 2017 Belete B, et al. This 
is an open access article distributed 
under the terms of the Creative 
Commons Attribution License, which 
permits unrestricted use, distribution, 
and reproduction in any medium, 
provided the original author and source 
are credited. 
Funding: University of Gondar 
Competing Interests: The authors 
declare that this manuscript was 
approved by all authors in its form and 
that no competing interest exists. 
Affiliation and Correspondence: 
1Department of Clinical Chemistry, 
School of Biomedical and Laboratory 
Sciences, University of Gondar, 
Ethiopia 
2Institute of Public Health, College of 
Medicine and Health Sciences , 
University of Gondar, Ethiopia 
3Department of Paraclinical Studies, 
Faculty of Veternary Medicine, 
University of Gondar, Ethiopia 
       *Email: beletebiadigo@yahoo.com 
 
 
 
 
 
 
 
 
ABSTRACT  
 
BACKGROUND:  The problem of dyslipidemia is high in patients 
with diabetes mellitus. There is ample  evidence that 
abnormalities in lipid metabolism are important risk factors for 
increased incidence of diabetes associated complications. The 
most important risk indicators for these complications are lipid 
profile abnormalities. Therefore, the aim of this study was to 
assess the correlation between serum lipid profile with 
anthropometric and clinical variables among type 2 diabetes 
mellitus patients. 
METHODS: A comparative cross sectional study was conducted 
at University of Gondar Hospital from February to April in 2015. 
A total of 296 participants (148 case and 148 healthy controls) 
were selected using systematic random sampling technique. 
Socio- demographic characteristics and clinical data were 
collected using pretested structured questionnaire incorporating 
the WHO Stepwise approach. Fasting venous blood sample was 
collected for blood sugar; lipid profile investigations and the 
blood levels were determined by Bio Systems A25 Chemistry 
Analyzer (Costa Brava, Spain). Independent sample t-test and 
Man Whitney U test were used to compare means. P-value < 0.05 
was considered statistically significant. 
RESULTS: Overall, T2DM patients had significantly higher total 
cholesterol ([205.4±50.9vs184.9±44.1]mg/dl), low density 
lipoprotein ([113.1±43.2vs100.1±36.4] mg/dl) and triacylglycerol 
([189.22± 100.9 vs 115.13±59.2] mg/dl), and significant decline of 
high density lipoprotein cholesterol ([56.5±20.4vs62.1±13] mg/dl) 
as compared to healthy controls, respectively. Triacylglycerolemia 
was significantly associated with the risk of cardiovascular 
disease (AOR: 1.015; 95%CI: 1.010-1.021). Evident correlation 
was observed between anthropometric and clinical variables with 
lipid profile. 
CONCLUSIONS: Higher serum levels of fasting blood sugar, 
total cholesterol, low density lipoprotein cholesterol, and 
triacylglycerol and lower levels of high density lipoprotein 
cholesterol are found in type 2 diabetes mellitus patients. Thus, 
DM patients are more prone to dyslipidemia which is an  
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important risk factor for atherosclerosis and 
coronary heart disease. 
KEYWORDS: Type 2 diabetes mellitus, lipid 
profile, Ethiopia 
 
INTRODUCTION 
 
Diabetes mellitus (DM) is a group of metabolic 
disorder of multiple etiologies. It is 
characterized by chronic hyperglycemia with 
disturbances of carbohydrate, protein and lipid 
metabolism resulting from defects in insulin 
secretion, action, or both (1).  
Diabetes Mellitus can be grouped into 
different clinical classes. 5-10% of diabetes 
cases is type 1 DM. It is mostly diagnosed 
during childhood ages and  caused by β -cell 
damage resulting in diminished ability of the 
pancreas to produce insulin. The second class is 
type 2 diabetes mellitus (T2DM). It constitutes 
over 80-90% of all DM cases and is mostly 
diagnosed after the age of 40. However, younger 
cases are being reported recently. Insulin is 
usually produced but not properly utilized due to 
insulin resistance (IR) in the target cells and 
gestational DM which is defined as first 
recognition of DM during pregnancy (2,3). 
The major chronic complications of DM are 
microvascular and macrovascular (4). The 
overall temporal burden of hyperglycemia is 
responsible for the  complications and adverse 
outcomes (5). These complications are common 
in sub-Saharan Africa due to various reasons 
like lack of community awareness,  poor 
laboratory and clinical diagnosis. As a result of 
the above reasons, people with DM regularly 
visit the health facilities because of complication 
rather than for routine medical checkup (6). It 
requires continuing medical care and ongoing 
patient self-management education and support 
to prevent and reduce complications (7). 
Multiple risk factors are responsible for the 
development of T2DM such as behavioral and 
environmental risk factors (8). Concordance 
among monozygotic twins is close to 100%, and 
25% of those with the disease have a family 
history of DM (9). The environmental factors in 
the pathogenesis of T2DM are obesity, physical 
inactivity, increase in alcohol intake, over eating 
and smoking (10).  
Diabetes Mellitus currently affects about 5% of 
the world’s population, and its prevalence is 
rapidly increasing particularly in elderly people 
(11,12). It is evolving as one of the most 
important chronic health problems in Ethiopia 
(13). The estimated prevalence of DM in adult 
population of Ethiopia is 1.9% (13). WHO 
estimated the number of diabetic cases in 
Ethiopia as 800,000 by the year 2000, and the 
number is expected to increase to 1.8 million by 
2030 (15). A community based study in Gondar, 
Northwest Ethiopia, showed that the prevalence 
of DM among adults aged 35 years and above 
was 5.1% for urban and 2.1% for rural dwellers 
(16).  
Lipid abnormalities are prevalent in DM 
patients because of IR which affects key 
enzymes and pathways in lipid metabolism: Apo 
protein production, regulation of lipoprotein 
lipase, action of cholesterol ester transfer 
proteins and hepatic and peripheral actions of 
insulin (17). Hyperglycemia and the high level 
of IR associated with T2DM has multiple effects 
on fat metabolism which results in the 
production of atherogenic dyslipidemia 
characterized by lipoprotein abnormalities: 
elevated very low density lipoprotein cholesterol 
(VLDL) elevated low density lipoprotein 
cholesterol (LDL-c), elevated triacylglycerol 
(TAG) and decreased high density lipoprotein 
cholesterol (HDL-c) which are  measured for 
cardiovascular risk prediction (18-22).  
The duration of diabetes, degree of 
hyperglycemia, hypertension, dyslipidemia and 
smoking are the strongest risk factors for chronic 
complications of DM that leads to biochemical 
aberrations (23). Appropriate management 
targeting glycemic, hypertension and lipid 
control is important for decreasing morbidity 
and mortality, and improving long term quality 
of life for patients diagnosed with T2DM. 
Lifestyle changes such as nutrition therapy, 
weight loss, regular physical exercise, 
appropriate education and self-management 
strategies are vital to improve outcomes (24, 25). 
Therefore, the aim of this study was  to assess 
the correlation between lipid profile with 
anthropometric and clinical variables in patients 
with T2DM at University of Gondar Hospital, 
Northwest Ethiopia. 
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METHODS AND MATERIALS 
        
Study design, period and area: A comparative 
cross-sectional study was conducted from 
February to April, 2015 at Gondar University 
Hospital Chronic Illness Clinic, Northwest 
Ethiopia. Gondar Town is 738 km far from 
Addis Ababa, the capital city of Ethiopia. The 
town has around nine government health centers 
and one university hospital. University of 
Gondar Hospital provides health service for 
more than 5 million inhabitants in northwest 
Ethiopia. It plays an important role in teaching, 
research and community service. The hospital 
gives service for more than 8000 diabetic 
patients. 
Sample size and study subjects: The sample 
size was calculated based on two population 
mean formula using Open Epi Info version 2, 
open source calculator  by considering 95% 
confidence interval (2-sided) and 80% power. 
Ratio of sample size (T2DM group/control 
group) is 1. We used mean ± SD of 4.41 ± 1.39 
and 3.98 ± 1.24 for cases and controls, 
respectively (26). Therefore, the total sample 
size was 296 (equal number of cases and 
controls). All T2DM patients attended to   the 
institution were included using systematic 
random sampling technique. All T2DM patients 
attending at University of Gondar Hospital were 
included in the study.In addition, age and sex 
matched apparently healthy individuals were 
employed as a control group. On the other hand, 
patients who already had any chronic diseases, 
pregnant women and patients on statins for 
abnormal lipid treatment and on insulin therapy, 
smokers, alcoholics and those who were on 
anticoagulant drugs were excluded from the 
study.  
Data collection and laboratory methods: 
Patients were asked to fill the written consent 
form after pre-test was conducted in 5% of the 
study participants. Data on socio-demographic 
characteristics were collected by trained nurses 
from University of Gondar Hospital Chronic 
Illness Clinic by using semi-structured 
questionnaire. Anthropometric variables 
including body mass index (BMI) and waist 
circumference (WC) were measured. BMI was 
calculated as weight in kilogram divided by 
height in centimeter square. WC was taken 
midway between the lowest rib and the iliac 
crest. Cut off values for anthropometric and lipid 
profile values were based on the National 
Cholesterol Education Program-Adult Treatment 
Panel III (NCEP-ATP III) guidelines. Abnormal 
lipid profile was defined as TC ≥200 mg/dl, 
HDL-c < 40mg/dl, LDL-c ≥130 mg/dl, and TAG 
≥150mg/dl (19). An elevation of any one of the 
lipid parameters to a level above these limits 
was considered as dyslipidemia. Blood pressure 
was taken by qualified personnel using an 
analogue sphygmomanometer and stethoscope. 
Duplicate measurements were taken from the 
upper arm with the hand at the heart level after 
the patient had been sitting for more than 5 
minutes and the averaged value was recorded. 
Five milliliter blood sample was collected from 
the patients by a laboratory technologist for lipid 
profile investigation after 10-12 hour fasting. 
Glucose and lipid profile levels were measured 
by glucose oxidase and direct enzymatic 
methods, respectively using Bio systems A25 
(Costa Brava, Spain) automated clinical 
chemistry analyzer according to manufacturer’s 
instructions.  
Data management and quality control: The 
questionnaire was pre-tested for accuracy and 
consistency prior to actual data collection  and a 
half day training was given to data collectors. 
Furthermore, the principal investigator gave 
feedback and corrections on daily basis to the 
data collectors. The completion, accuracy, and 
clarity of the collected data were checked 
carefully on a regularly basis. Normal and 
pathological control samples were run daily in 
order to check the optimal reactivity of the 
reagent and functionality of the analyzer. The 
results obtained from control samples should be 
within mean ± 2SD of the given Levy Jenning 
chart. Therefore, to maintain the quality of the 
result, pre-analytical, analytical and post- 
analytical precautions of quality, depending on 
the stated SOP, were considered. Appropriate 
remedies were taken in cases of unacceptable 
quality control results. Finally, the sample was 
processed within 1 hour of specimen collection 
in the clinical chemistry laboratory and 
processed based on the manufacturer’s manual. 
Data analysis and interpretation: Data were 
entered and analyzed using SPSS version 20 
                 
         Ethiop J Health Sci.                               Vol. 27, No. 3                      May 2017 
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v27i3.3 
 
218 
 
(IBM, USA). The data were tested for normality 
with the help of histograms, comparison of 
means and medians, skewness and the 
Kolmogorov-Smirnov test. Data were reported 
as mean and standard deviation for continuous 
variables, percentages for categorical variables 
and interquartile range for non-normally 
distributed data. Variables were compared using 
independent sample t-test for normally 
distributed data and Mann-Whitney U test for 
non-normally distributed data. Pearson’s and 
spearman’s rank correlations were used to test 
the relationship of lipid profile with clinical and 
anthropometric variables. P-value <0.05 was 
considered statistically significant. 
 Ethical consideration: Ethical clearance was 
taken from Research and Ethical Committee of 
the School of Biomedical and Laboratory 
Sciences, University of Gondar, and permission 
was secured from both the Medical Director and 
the head of the Chronic Illness Clinic of  the 
Hospital. In addition, written informed consent 
was obtained from the study participants before 
data collection.  
 
RESULT 
 
Socio-demographic characteristics of the 
study participants: A total of 296 (148 T2DM 
and 148 controls) study participants  were 
participated in this study. Of the total T2DM 
patients, 59(39.9%) and 89(60.1%) were males, 
females respectively. Similarly, of the 148 
healthy controls 89(60.1%) were females. The 
overall mean age was 49.09± 8.1 and 47.8± 6.7 
years for T2DM and controls respectively. The 
residence of the majority, 278 (93.9%), of the 
participants was  urban. Summary of the other 
demographic variables are presented in (Table 
1). 
 
Table 1:  Socio-demographic characteristics of study participants at University of Gondar Hospital, 
Northwest Ethiopia, 2015 (N=296). 
 
Variables T2DM % (N=148) Controls % (N=148) P-value 
Age in year                                                       0.071 
  25-34 5(3.4) 4(2.7)  
  35-44 32(21.6) 36(24.3)  
  45-54 72(48.7) 83(56.8)  
  55-64 36(24.3) 24(16.2)  
  65+ 3 (2.0) 1(0.7)  
Sex   1.00 
  Male 59 (39.9) 59 (39.9)  
  Female 89 (60.1) 89 (60.1)  
Residence                                      0.052 
  Urban 135(91.2) 143(96.6)  
  Rural 13(8.8) 5(3.4)  
Religious   0.745 
  Orthodox 135(91.2) 139(93.9%)  
  Muslim 11(7.4) 5 (3.4)  
  Protestant 2 (1.4) 4 (2.7)  
Marital status   0.135                              
  Single 8(5.4) 16(10.8)  
  Married 106(71.6) 108(73.0)  
  Divorced 12(8.1) 12(8.1)  
  Widowed 19(12.8) 10(6.8)  
  Separated 3(2.0) 2(1.4)  
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Clinical features and anthropometric 
measurements of the study participants: The 
result showed that the mean levels of BMI, 
WHR, systolic BP and diastolic BP were 
significantly higher (P<0.05) in T2DM 
compared to controls. The median duration of 
illness since diagnosis was 3 years for T2DM 
patients. From the total study participants, 
72(48.6%) and 35 (23.6%) were overweight 
cases and controls, respectively. The mean WC 
showed statistically significant difference 
between the two groups (83.02±12.6 and 
78.67±10.1), p<0.001 respectively (Table 2). 
 
Table 2: Clinical features and anthropometric measurements of the study participants at University of 
Gondar Hospital, Northwest Ethiopia, 2015 (n=296). 
 
 
Variables T2DM% (N=148) Controls % (N=148) P-Value 
BMI (Kg/m
2
)   0.000 
Underweight 2 (1.4) 7(4.7)  
Healthy weight 62 (41.9) 101(68.2)  
Over weight 72(48.6) 35(23.6)  
Obese 12(8.1) 5(3.4)  
WC(cm)   0.001 
Low risk 85(57.4) 109(73.7)  
Increased risk 25(17) 14(9.5)  
High risk 38(25.7) 25(17)  
WHR
©
 0.88± 0.88 0.84±0.66 0.000 
Blood pressure (mmHg)    
Systolic BP 130(120-140)* 110(110-120)* 0.000 
Diastolic BP 80(70-88)* 70 (70-80)* 0.000 
Duration since diagnosis (in year)    
<5 107(72.3) -  
≥5 41(27.7) -  
Median duration of DM in year      3(1-6)*    
Note: *Presented as median and interquartile range, © Presented as mean ± standard deviation BMI: Body Mass 
Index, WHR: Waist to Hip Ratio, FBS: Fasting Blood Sugar, BP: Blood Pressure, WC: Waist Circumference 
 
Comparison of lipid profile and Fasting blood 
sugar level of the study participants: 
Significant increase in TC, LDL-c, TAG and 
FBS concentrations were observed in diabetic 
patients (205.4±50.9 vs 184.9±44.1, 113.1±43.2 
vs 100.1±36.4, 189.22± 100.9 vs 115.13±59.2 
and 163.7±1.33 vs 81.3 ±1.08 (p<0.05) as 
compared to the control group respectively. On 
the contrary, there was a significant decline in 
mean concentration of HDL-c in T2DM 
compared to controls (56.5±20.4 vs 62.1±13) 
p=0.007 respectively (Table 3). 
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Table 3: Comparison of lipid profiles and Fasting blood sugar concentration of the study participants 
using t-test at University of Gondar Hospital, Northwest Ethiopia, 2015 (n=296). 
 
Variables Mean± SD T2DM Mean± SD Controls P- value 
Lipid profiles (mg/dl)    
Total cholesterol 205.4±50.9 184.9±44.1 0.000 
Triacyl glycerol 189.22± 100.9 115.13±59.2 0.000 
High density lipoprotein 56.5±20.4 62.1±13.5 0.007 
Low density lipoprotein 113.1±43.2 100.1±36.4 0.009 
Fasting blood sugar (mg/dl) 163.7±1.33 81.3 ±1.08 0.000 
Note: SD: Standard deviation, T2DM: Type 2 Diabetes Mellitus 
 
The most commonly observed lipid 
abnormalities in the study was TAG 94(63.5%) 
followed by raised LDL92 (62.2%), 
hypercholesterolemia 80(54.1%) and low HDL 
cholesterolemia 24(16.2%) for T2DM patients. 
Raised LDL cholesterolemia 76(51.4%) 
followed by hypercholesterolemia 51(34.5%), 
hypertriacylglycerolemia 40 (27%) and  low 
HDL cholesterolemia 2(1.4%) were reported in 
controls. The proportions of lipid profile 
disorders were higher in DM patients compared 
to apparently healthy controls (Figure 1). 
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Figure 1: Proportions of diabetes mellitus patients and controls in relation to lipid profile concentrations 
at University of Gondar Hospital, Northwest Ethiopia, 2015 
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The association between CVD risk of lipid 
parameters effects on type 2 diabetic and 
non-diabetic participants: The serum lipid 
profile associated risks were evaluated by using 
univariate and multivariate logistic regression 
analysis and summarized in (Table 4). Bivariate 
logistic regression analysis revealed that the 
higher lipid values of TC, TAG, HDL 
cholesterol and LDL cholesterol were 
significantly (p<0.001) associated with the risk 
of developing CVD among T2DM and control 
subjects. Further, adjusted multivariate logistic 
regression analysis confirmed that TAG 
(OR=1.015, 95% CI=1.010-1.021, p=0.000) 
were the significant and independent risk factors 
for CVD among T2DM patients (Table 4). 
 
Table 4: The association between cardiovascular disease risk and serum lipid concentrations of T2DM 
and non-diabetic subjects at University of Gondar Hospital, Northwest Ethiopia, 2015 
 
Variable Unadjusted OR (95% CI) P-Value Adjusted OR (95% CI) P-Value 
Total cholesterol 1.009 (1.004-1.014) 0.000* 1.003(0.989-1.017) 0.690 
Triacylglycerol 1.016 (1.012-1.021) 0.000* 1.015 (1.010-1.021) 0.000* 
High density 
lipoprotein 
0.982 (0.969-0.995) 0.008* 0.992(0.972-1.012) 0.415 
Low density 
lipoprotein 
1.008 (1.002-1.014) 0.010* 1.002 (0.986-1.018) 0.817 
Note: OR: Odds Ratio, CI: Confidence Interval, *: Statistically significant association 
 
Correlations between lipid profiles with FBS, 
Duration of DM and Anthropometric 
measurements of study participants: There 
was non-significant negative correlation 
between BMI and HDL, where as a statistically 
significant positive correlation existed in other 
lipid profiles in both diabetic and control groups. 
Waist to hip ratio (WHR) achieved a statistical 
significant positive correlation with Total 
cholesterol (p=0.000), Low density lipoprotein 
(p=0.000) and Triacylglycerol (p=0.015) in 
T2DM (Table 5). 
 
Table 5: Pearson’s correlations(r) between lipid profiles with BMI and WHR among T2DM and healthy 
controls at University of Gondar Hospital, Northwest, Ethiopia, 2015, (n=296). 
 
 
     Type 2 DM group     Control group 
Variables BMI WHR BMI WHR 
     r(p)     r(p)      r(p)     r(p) 
Low density lipoprotein 0.293**(0.000) 0.283**(0.000) 0.364**(0.000) 0.349**(0.000) 
High density lipoprotein -0.053(0.519) -0.025(0.766) -0.172(0.036) -0.065(0.431) 
Total cholesterol 0.167*(0.042) 0.349**(0.000) 0.231
**
(0.005) 0.396**(0.000) 
Triacylglycerol 0.335**(0.000) 0.200*(0.015) 0.499
**
(0.000) 0.117(0.156) 
 
Note:  BMI: Body Mass Index, WHR: Waist to Hip Ratio, ** and *: Correlation is significant at 0.01 level 
and 0.05 level (2-tailed) respectively) 
 
The correlation between systolic BP among 
various lipid profiles showed statistically 
significant correlation inT2DM and control groups 
for TAG. However,  diastolic BP was not found to 
have statistically significant correlation with any 
of the lipid profiles (Table 6). In the T2DM 
groups, FBS showed a significant positive 
correlation with TAG and LDL. There was no 
significant correlation observed among any of 
lipid profiles in the control group. Duration of 
T2DM also significantly correlated with Low 
density lipoprotein and total cholesterol (Table 6). 
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Table 6: Correlations between lipid profiles with Systolic,  diastolic blood pressure, FBS and duration of 
DM among T2DM and healthy controls at University of Gondar Hospital, Northwest, Ethiopia, 2015, 
(n=296). 
 
Note: SBP: Systolic Blood Pressure, DBP: Diastolic Blood Pressure, FBS: Fasting Blood Sugar, T2DM: Type 2 
Diabetes Mellitus, ** and *: Correlation is significant at 0.01 level and 0.05 level (2-tailed) respectively), r: 
Pearson’s correlation coefficient, rho: Spearman’s rank correlation coefficient.   
 
DISCUSSION 
 
This study showed a significant increase in TC, 
LDL cholesterol and TAG in diabetic patients 
compared to the control group. In addition, there 
was a significant decline in mean concentration of 
HDL cholesterol in T2DM patients compared to 
controls. These phenomena indicate the 
occurrence of risk factors for CVD which  was 
documented by several studies in agreement to 
this study (27-33). Hypertriacylglycerolemia 
(63.5%) was the major lipid parameter disorder in 
our study. This finding is in concord with previous 
studies in Hyderabad (60%) and Sudan (48.8%) 
(28,31). This is due to the fact that increased 
hepatic secretion of VLDL and delayed clearance 
of TAG rich lipoproteins increased levels of 
substrates for TAG production, enhanced 
mobilization of free fatty acid (FFA) from adipose 
tissue and increased in the blood of DM patients 
as observed in the present study (34). Elevated 
TAG levels are a common dyslipidemic feature 
accompanying T2DM and prediabetes states (35). 
A fasting TAG level of greater than 150 mg/dl is 
one of the accepted criteria for defining 
individuals at high risk for CVD and T2DM (36). 
Our study showed raised TAG, LDL and low 
HDL cholesterol levels in DM patients. This result 
is similar to Asian Pacific Cohort Studies 
Collaboration (37). According to the CDC, 97% of 
adults with diabetes have one or more lipid 
abnormalities (38). On contrary to previous 
studies, TC and LDL cholesterol were raised in 
our finding (37,29) in T2DM patients. Another 
study showed that there is no statistically 
significant difference in serum TC and LDL 
cholesterol concentration in diabetic patients 
compared to control groups  which is inconsistent 
to our study (29,32).  In contrast to our result, 
(16.2%), HDL cholesterol dyslipidemia in T2DM 
is higher in previous studies in Hyderabad (71%), 
Nepal (20%), Sudan (93%) and Ghana (26%) 
(27,28,30,31). The variation is due to differences 
in genetics, life style difference and management 
of diabetes in the particular group being studied. 
     Type 2 DM group Control group 
Variables  SBP 
rho(p) 
DBP 
rho(p) 
SBP 
rho(p) 
DBP 
rho(p) 
     
Low density lipoprotein  0.071(0.391) 0.039(0.634) 0.078 (0.348) 0.066(0.429) 
High density lipoprotein -0.020(0.813) -0.008(0.927) -0.008(0.927) -0.060(0.471) 
Total cholesterol 0.079(0.342) 0.039(0.634) 0.024(0.772) 0.074(0.369) 
Triacylglycerol 0.723*(0.001) 0.059(0.473) 0.240*(0.003) 0.153(0.064) 
Variables FBS Duration of T2DM FBS  
 r(p)    r(p) r(p)  
Low density lipoprotein 0.173*(0.035) 0.303**(0.000) 0.076(0.359)  
High density lipoprotein  -0.101(0.220) -0.010(0.900) -0.059(0.477)  
Total cholesterol 0.096(0.247) 0.408**(0.000) 0.089(0.281)  
Triacylglycerol 0.225**(0.006) 0.115(0.166) 0.057(0.495)  
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 Previous study reported that lipid 
compositions of various tissues altered in diabetes 
(39). Hence, it is postulated that circulatory lipids 
play a vital role in progression of T2DM, not only 
by way of lipid abnormalities but also by 
modifying the composition, structure and firmness 
of cellular membranes (39). Several studies 
reported high levels of TAG, TC and LDL-c 
among diabetic patients, a finding observed in the 
present study too. However, another study in 
Nigeria reported a different finding (33) which is 
higher TAG in controls. The main cause for lipid 
abnormalities in T2DM patients is impaired 
secretion of insulin that affects the liver 
apolipoprotein production and regulates the 
enzymatic activity of lipoprotein lipase (LpL) and 
cholesterol ester transport protein (CETP). 
Moreover, its deficiency reduces the activity of 
hepatic lipase; therefore, several steps involved in 
the production of biologically active LpL might be 
altered in T2DM compared to controls. 
Generally, T2DM is associated with low 
HDL cholesterol levels, which is an independent 
cardiovascular risk factor. The low concentrations 
reflect a dysregulation in HDL metabolism. It is 
determined by the concerted action of different 
proteins, including CETP, lecithin cholesterol 
acyltransferase, LpL, phospholipid transfer 
protein, hepatic lipase and dysfunctional HDL-
mediated reverse cholesterol transport are 
impaired in T2DM patients compared to controls 
(40). The association between dyslipidemia and 
risk of CVD is biologically plausible and   
compatible with what is known about 
pathophysiology of CVD. The hypothesized 
mechanism for dyslipidemia and CVD association 
has been described. Investigators noted that 
elevated plasma lipid and lipoprotein may induce 
endothelial dysfunction secondary to oxidative 
stress (22. Other mechanism is pathologic process 
of CVD via dysregulation of LpL resulting in a 
dyslipidemic lipid profile (19). 
In this study, we also tried to correlate lipid 
profiles with various clinical and anthropometric 
variables. The variables above the threshold cut 
off values were found to be predictors of CVD in 
various populations. In the present study, we 
observed statistically significant increases in the 
mean values of BMI and the WC in T2DM 
participants  compared to the controls. Similar 
findings were observed by other researchers 
(41,42). In the present study, lipid profile 
correlated in a comparable manner with BMI and 
WHR. This finding is consistent with a previous 
study (43) which showed positive correlation 
between BMI and WHR with respect to TC, TAG. 
However,  previous study reported that correlation 
existed only in BMI and VLDL (44).  
A recent study, in agreement with this study, 
demonstrated significant differences in 
anthropometric variables and lipid profile in 
T2DM in three different ethnic groups in Malaysia 
(45). In another recent study in Iranian, it was 
observed that correlation happened between BMI 
and TC, LDL cholesterol, TAG in concord to our 
study (46). Another recent study from North India, 
agreement to this study, reported positive 
correlations between WHR, TC, LDL cholesterol 
in healthy subjects in (47).  
Other study in Saudi Arabia and Korean, 
consistent to this study, reported that there was a 
positive correlation between BMI with TC, LDL 
and WHR with TC, LDL respectively, but in 
contrast to ours, no correlation was seen between 
BMI and TAG in Saudi Arabia study (48,49). A 
similar study in Brazil demonstrates an association 
between the lipid profiles and body adiposity (50).  
Interrelation between level of BP and lipid 
profiles may be through diabetes related to the 
development of hypertension and dyslipidemia 
(51, 52). In our study, the mean systolic and 
diastolic BP is significantly higher in T2DM 
patients compared to healthy controls. This is due 
to peripheral resistance which is a major factor 
influencing diastolic BP, influenced by narrowing 
of blood vessels in T2DM patients that increases 
diastolic BP (53). In contrast to our study, a 
prospective analytical study found a significant 
positive correlations of TC, LDL cholesterol with 
BP (54). A study on patients diagnosed as 
hypertension found that TC and LDL cholesterol 
were associated closely with level of BP (55). 
Another recent cross sectional survey on 32004 
patients showed that co-existence of high BP and 
abnormal glucose metabolism was common in 
Chinese population (56). A study demonstrated an 
association between hypertension and 
hypertriglycerolemia with poor glycemic control 
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consistent to our study (57). Noteworthy is the fact 
that different to previous studies, our results did 
not show any correlation between BP and lipid 
profile in T2DM patients except TAG. 
In our study, FBS had statistically significant 
correlation with TAG and LDL cholesterol in 
T2DM. Congruent to our study, a study in India 
reported higher TC, TAG and LDL cholesterol in 
patients who have poor glycemic control (58), in 
Nepal on T2DM reported that significant 
correlations with TC, LDL cholesterol, and 
significant negative correlation with HDL 
cholesterol (59). In contrast to our study, a study 
on healthy population in India showed, significant 
correlation of FBS with TAG, LDL and  negative 
correlation to HDL cholesterol. Similar to our 
study, no correlation of FBS with TC in control 
groups (60).Duration of DM achieved significant 
correlation with LDL cholesterol, TC. Studies in 
India found that chronicity of T2DM cause higher 
lipid disturbance (57) which is observed in our 
study. According to United Kingdom prospective 
study risk score for CVD (61,62), duration of 
diabetes was associated with higher incidence of 
dyslipidemia of TC, LDL cholesterol in agreement 
to our study. 
In conclusion, there was statistically 
significant difference in lipid profile level between 
diabetic patients and apparently healthy controls. 
The study also reported that significant increase in 
FBS, systolic and diastolic BP, BMI, WC in 
diabetics than apparently healthy controls. 
Significant correlation was observed in lipid 
profiles with anthropometric and clinical 
variables. This is a reflection of poor glycemic 
control and life style changes. This suggests a 
necessity in educating T2DM patients about 
regular follow-up and appropriate glycemic 
control to prevent and delay the progression of the 
disease. Periodic medical checkup and appropriate 
life style change is recommended for apparently 
healthy controls to improve the quality of 
interventions not only to achieve weight loss goals 
but also to control dyslipidemia and reduce 
cardiovascular risk. Thus multi-center prospective 
studies with larger cohort may be needed in the 
future. 
 
ACKNOWLEDGEMENT 
 
We express our deepest gratitude to all of the 
study participants. We also would like to 
acknowledge the University of Gondar Hospital 
laboratory staff members and Mr. Desalew 
Wudineh for their cooperation during data 
collection.  
 
REFERENCES 
 
1. American Diabetes Association. Diagnosis and 
Classification of Diabetes Mellitus. Diabetes 
care.2008; 31 (1):S55-S60. 
2. Annette H, Hilde L and Elisabete W. Obesity and 
diabetes epidemics cancer repercussions. 
Innovative endocrinology of cancer, edited by 
LevM. Berstein and Richard J.Santen, 2008; 73. 
3. American Diabetes Association. Standards of 
Medical Care in Diabetes. Diabetes Care .2014; 
37(1):S14. 
4. Fauci A, Braunwald E, Kasper D, Hauser S, Longo 
D. Harrison’s Principles of Internal Medicine. 17th 
edition. United States of America. The McGraw 
Hill Company; 2008. 
5. Rizvi A, Sanders MB. Assessment and monitoring 
of Glycemic control in primary diabetes care: 
monitoring techniques, record keeping, tests of 
average glycaemia, and point of care evaluation. J 
Am Acad Nurse Pract .2006; 18:11–21. 
6. Africa diabetes leader ship forum (DLF). Diabetes: 
the hidden pandemic and its impact on sub-Saharan 
Africa. Johannesburg 2010. 
7. American diabetes association. Standards of 
medical care in diabetes. Diabetes cares.2013; 36 
(1): S11. 
8. Rother KI. Diabetes treatment bridging the divide. 
N Engl J Med.2007; 356(15):1499-1501. 
9. Florez JC. Clinical review: the genetics of type 2 
diabetes: a realistic appraisal in 2008. J Clin 
Endocrinol Metab.2008; 93: 4633-4642. 
10. Kaku K. Pathophysiology of type 2 DM and its 
treatment policy. JMAJ .2010; 53(1):41-46. 
11. Reinehr T. Type 2 diabetes mellitus in children and 
adolescents. World J Diabetes. 2013; 4(6): 270-
281. 
12. Laakso M. Heart in diabetes: a microvascular 
disease. Diabetescare. 2011; 34 (2): S145-S149. 
13. Abdulkadir J, Reja A. Management of diabetes 
mellitus: Coping with limited facilities. Ethiop 
Med J .2001; 39:349-365. 
    Correlation between Lipid Profile with Anthropometric and …             Belete B. et al                                    
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v27i3.3 
 
225 
14. Alemu S, Dessie A, Seid E, Bard E, Lee PT, 
Trimple ER, et al. Insulin requiring diabetes in 
rural Ethiopia, Should we reopen the case for 
malnutrition related diabetes? Diabetologia. 2009; 
52:1842-1845.   
15. Naheed G. Knowledge, Attitudes and Practices of 
Type 2 Diabetics Mellitus. J Ayub MedColl 
Abbottabad. 2010; 22(3). 
16. Abebe SM, Berhane Y, Worku A, Assefa A. 
Diabetes mellitus in North West Ethiopia: a 
community based study. BMC public health. 2014; 
14(1):97. 
17. Frank B, Stampfer J, Steven M. Elevated risk of 
cardiovascular disease prior to clinical diagnosis of 
type 2 diabetes.  Diabetes Care.2002; 25:1129-34.  
18. Shahid SH. Frequency distribution of atherogenic 
dyslipidemia in Saudi type 2 diabetic patients. Pak 
J physiol.2006; 2(2):20-23. 
19. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, 
Clark LT, Hunning hake DB. Implications of 
recent clinical trials for the National Cholesterol 
Education Program Adult Treatment Panel III 
guidelines. Circulation.2004; 110(2):227–39. 
20. Nigam PK. Serum Lipid Profile: Fasting/Non-
fasting? IndJ Clin Biochem.2011; 26(1):96 97. 
21. Mullugeta Y,  Chawla R , Kebede T , Worku Y. 
Dyslipidemia Associated with Poor Glycemic 
Control in Type 2 Diabetes Mellitus and the 
Protective Effect of Metformin Supplementation. 
Ind J ClinBiochem. 2012; 27(4):363–369. 
22. Maitra A. The Endocrine System. In: Kumar V, 
Abbas AK, Fausto N, Aster JC, editors. Robbins 
and Cotran Pathologic Basis of Disease. 8
th
ed. New 
Delhi: Elsevier; 2010, 1097–164. 
23. Marshall SM, Flyvbjerg A: Prevention and early 
detection of vascular complications of diabetes. 
BMJ. 2006; 333:475-480. 
24. Redmon B, Caccamo D, Flavin P, Michels R, 
Myers C, O’Connor P, et al. Institute for Clinical 
Systems Improvement. Diagnosis and Management 
of Type 2 Diabetes Mellitus in Adults. 2014. 
25. Solano MP and Goldberg RB. Lipid Management 
in Type 2 Diabetes. Clini.Diabetes.2006; 24(1):1-
6. 
26. Samuel AA, Pius DO,  Adeyemi OB, Adeola TNA 
, Jimoh AK, Adepeju AA. Liver Enzymes and 
Lipid Profile among Type 2Diabetic Patients in 
Osogbo, Nigeria. Greener J.Medical 
Sciences.2013; 3 (5):174-178. 
27. Ramu K, Vinayak E, Shegokar. A study of lipid 
profile in patients with type 2 diabetes mellitus. 
Journal of health sciences.2013; 1(1): 23-27. 
28. Shaikh MA, Kumar S, Ghouri RA. Type 2 diabetes 
mellitus and lipid abnormalities. JLUMHS. 2010; 
9(03):145. 
29. Dahal S, Baral BK, Baral S, Shrestha R and 
Khanal M. Study of fasting serum lipid and 
lipoproteins profile in type II diabetic patients. 
Nepal Med Coll J.2013; 15(1): 18-22 
30. Tagoe DNA, Amo-Kodieh P. Type 2 diabetes 
mellitus influences lipid profile of diabetic 
patients. Annals of Biological Research.2013; 4 
(6):88-92. 
31. Elnasril H.A. and Ahmed A.M. Patterns of lipid 
changes among type 2 diabetes patients in Sudan. 
Easte. Mediter. Health Journal.2008; 14(2): 314-
324. 
32. Sahibzada SJ, AmirRehman, RA, Taj MK, Aziz A, 
Amjad A. Evaluation of pattern of dyslipidemia in 
type 2 diabetics in swat. Gomal J. Medic Sciences. 
2011; 9 (2):243-247. 
33. Oluyomia EOB, Fisayo AM, Bayodea FJ, 
Kehindea FM and Ademigbuji E. Adedayoa. Lipid 
profile of a group of Nigerian diabetic patients. 
Archives of Appli. Sci .Research.2010; 2 (4): 302-
306. 
34. Mooradian AD.Dyslipidemia in type 2 diabetes 
mellitus. Nat Clin Pract Endocrinol Metab. 2009; 
5:150–9. 
35. Ginsberg HN, Zhang YL, Hernandez-Ono A: 
Regulation of plasma triglycerides in insulin 
resistance and diabetes. Arch MedRes.2005; 
36:232–240. 
36. Kahn R, Buse J, Ferrannini E, Stern M. The 
metabolic syndrome: time for a critical appraisal. 
Joint statement from the American Diabetes 
Association and the European Association for the 
Study of Diabetes. Diabetologia. 2005; 48:1684–
1699. 
37. Kengne PA, Patel A, Barzi F, Jamrozik K, Lam 
HT, Ueshima T, et al. Cholesterol, diabetes and 
major cardiovascular diseases in the Asia-Pacific 
region. Diabetologia.2007; 50:2289–97. 
38. Ansorge R. Lowering high triglycerides, 
cholesterol is very important in diabetes. 2008.  
39. Letícia AS, Deoliveira MS, Paula Salles AMF, Das 
Graças MC. Hemostatic changes in patients with 
type 2 diabetes mellitus. Rev Bras Hematol 
Hemoter.2010; 32 (6):482-488. 
40.  Linthout SV, Spillmann F,  Schultheiss HP, 
Tschöpe C. High-Density Lipoprotein at the 
Interface of Type 2 Diabetes Mellitus and 
Cardiovascular Disorders. Current Pharmaceutical 
Design, 2010, 16(13), 1504-1516. 
41. Hardev SS, Shyamal K, Karanjit SS. A study of 
correlation between lipid profile and waist to hip 
                 
         Ethiop J Health Sci.                               Vol. 27, No. 3                      May 2017 
 
 
DOI:  http://dx.doi.org/10.4314/ejhs.v27i3.3 
 
226 
 
ratios in patients with diabetes mellitus. 
Anthropologist.2008; 10:215-8. 
42. Srinivas C, Lakshmana NK, Mallikarjuna R, 
Kishore K, Kiran D, Surya NK. Relationship 
between anthropometric, metabolic parameters and 
fasting glucose in rural population of Andhra 
Pradesh. J Evolution Med Dent Sci.2014; 3:9094-
9. 
43. Raja Reddy P, Jayarama N, Mahesh V. 
Anthropometric Correlation of Lipid Profile in 
Healthy People in Rural Kolar. Interdiscip. Resea. 
Journal.2013; 3(4):2249-9598. 
44. Himabindu Y, Sriharibabu M, Alekhya K, 
Saisumanth K, Lakshmanrao N, Komali1 K. 
Correlations between anthropometry and lipid 
profile in type 2 diabetics. Indian J Endocrinol 
Metab. 2013; 17(4): 727–729. 
45. Blebil AQ, Hassan Y, Dujaili JA. Differences in 
demographics, lipid profile and other clinical 
characteristics among type 2 diabetic patients in 
the state of Penang, Malaysia according to gender 
and races. Asian J Pharm Clin Res. 2011; 4 
(2):130–3. 
46. Ghorbanian B. Relation between anthropometric 
indicators and serum lipid profiles as 
cardiovascular risk factors personals of Iranian 
Azarbayjan University of ShahidMadani. Euro. J. 
Sports Exer. Sci. 2012; 1 (3):52-58. 
47. Sandhu HS, Koley S, Sandhu KS. A study of 
correlation between lipid profile and waist to hip 
ratios in patients with diabetes mellitus. 
Anthropologist. 2008; 10:215–8. 
48. Al-Ajlan AR. Lipid Profile in Relation to 
Anthropometric Measurements among College 
Male Students in Riyadh, Saudi Arabia. Int J 
Biomed Sci .2011; 7 (2): 112-119. 
49. Sarah C, Edwin T. Anthropometric measures and 
lipid CHD risk factors in Korean Immigrants with 
Type 2 Diabetes. Cardiovasc Nurs. 2011; 26:414.   
50. Lisianny CCdN, Ferreira, Humberto JGdaS, 
Tatiana AL, Wagner LdoP. Relationship between 
lipid and hematological profiles with adiposity in 
obese adolescents.Rev Bras Hematol Hemoter. 
2013; 35 (3):163-6. 
51. Petitti DB, Imperatore G, Palla SL, Daniels SR, 
Dolan LM, Kershnar AK, et al. Serum lipids and 
glucose control: the SEARCH for Diabetes in 
Youth study. Arch Pediatr Adolesc Med. 2007; 
161:159-65. 
52. Kamara NT, Asiimwe S. Dyslipidaemia and 
hypertension among adults with diabetes in rural 
Uganda. Trop Doct.2010; 40:41-2. 
53. Subbalakshmi NK, Sathyanarayana Rao KN, 
Sheila R Pai. A comparative study 
oncardiovascular parameters and lipids in 
metabolic syndrome with and without diabetes 
mellitus.IJIRSET.2013; 11(2):1-3 
54. Nasri H, Behradmanesh S, Ahmadi A,  Baradaran 
A,  Nasri P, Rafieian-Kopaei M. Association of 
serum lipids with level of blood pressure in type 2 
diabetic patients. J Renal Inj Prev. 2014; 3(2): 43-
46. 
55. Qiao S, Ye Q, Dou Y, Li M, Kou Y, Qian D, et al. 
Analysis for hypertension and related risk factors 
of physical examination population. Int J Clin Exp 
Med.2013; 6:785-93. 
56. Sun NL, Wang HY, Huo Y. Blood pressure control 
and glucose metabolism status in hypertension 
specialty clinics in China. Zhonghua Nei Ke Za 
Zhi.2013; 52:654-8. 
57. Basit A, Hydrie MZ, Hakeem R, Ahmedani MY, 
Waseem M. Glycemic control, hypertension and 
chronic complications in type 2 diabetic subjects 
attending a tertiary care center. J Ayub Med Coll 
Abottabad.2005; 17: 63-80. 
58. Singh G, Kumar A. Impact of Chronicity on Lipid 
Profile of Type 2 Diabetics. Journal of Exercise 
Science and Physiotherapy.2013; 9(1): 46-50. 
59. Verma M,  Paneri S,  Badi P ,   Raman P.G. Effect 
of increasing duration of diabetes mellitus type 2 
on Glycated hemoglobin and insulin sensitivity. 
Indian J.Clini Biochemistry.2006; 21 (1):142-146. 
60. Agrawal J, Bharihoke N, Kar A. Moderate 
correlation of fasting blood sugar with different 
lipid Parameters may a signal for insulin resistance 
in normal population. Int J Pharm Pharm Sci. 
2014; 6(5): 683-685. 
61. Guzder R.N, Gatting W, Mullee M.A. Prognostic 
value of the Framingham cardiovascular risk 
equation and the UKPDS risk engine for coronary 
heart disease in newly diagnosed type-2 diabetes. 
Diabetes Med.2005; 22: 554-62. 
62. Talat N, Khan A, Gulsena M, Bilal B.  
Dyslipidemias in Type 2 Diabetes Mellitus Patients 
in a Teaching Hospital of Lahore, Pakistan. Pak. J. 
Med. Sci.2003; 19: 283-6. 
